Dermatologists and pharmacovigilance practitioners: A winning partnership for the management of cutaneous adverse drug reactions

被引：0
|
作者：
Lebrun-Vignes, B. [1 ,2 ,3 ,4 ,5 ]
机构：
[1] Sorbonne Univ Hosp Grp, APHP, Paris Pitie St Antoine Reg Pharmacovigilance Ctr, Med Pharmacol Dept, Paris, France
[2] FISARD Grp, Paris, France
[3] Reference Ctr Tox Bullous Dermatoses & Severe Drug, Creteil, France
[4] Univ Paris Est Creteil UPEC, Epidemiol Dermatol & Evaluat Therapeut Epi DermE E, Creteil, France
[5] Sorbonne Univ Hosp Grp, APHP, Reg Pharmacovigilance Ctr Paris Pitie St Antoine, Med Pharmacol Dept, 47-83 Blvd lHopital, F-75013 Paris, France
来源：
ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE | 2023年 / 150卷 / 03期
关键词：
D O I：
10.1016/j.annder.2023.05.003
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：169 / 170
页数：2
相关论文
共 50 条
  • [41] Pharmacovigilance of cutaneous adverse drug reactions among patients attending dermatology department at a Tertiary Care Hospital
    Sharma, Shweta
    Jayakumar, Dhanya
    Palappalli, Dhanya S.
    INDIAN DERMATOLOGY ONLINE JOURNAL, 2019, 10 (05) : 547 - 554
  • [42] Pharmacovigilance of cutaneous adverse drug reactions in associations with drugs and medical conditions: a retrospective study of hospitalized patients
    Zheng, Lei
    Jin, Hao-bin
    Guan, Yu-yao
    Yang, Jing
    BMC PHARMACOLOGY & TOXICOLOGY, 2022, 23 (01):
  • [43] Adverse drug reactions: A review for healthcare practitioners
    Young, LR
    Wurtzbacher, JD
    Blankenship, CS
    AMERICAN JOURNAL OF MANAGED CARE, 1997, 3 (12): : 1884 - 1906
  • [44] Pharmacovigilance of cutaneous adverse drug reactions in associations with drugs and medical conditions: a retrospective study of hospitalized patients
    Lei Zheng
    Hao-bin Jin
    Yu-yao Guan
    Jing Yang
    BMC Pharmacology and Toxicology, 23
  • [45] Outcomes of the management for patients with antituberculosis drug-induced cutaneous adverse drug reactions
    Thongraung, W.
    Rerkpattanapipat, T.
    Pungrassami, P.
    ALLERGY, 2013, 68 : 385 - 385
  • [46] Severe cutaneous adverse reactions associated with systemic ivermectin: A pharmacovigilance analysis
    Bomze, David
    Sprecher, Eli
    Geller, Shamir
    JOURNAL OF DERMATOLOGY, 2022, 49 (08): : 769 - 774
  • [47] Pharmacovigilance for evaluating adverse drug reactions: value, organization, and methods
    Montastruc, Jean-Louis
    Sommet, Agnes
    Lacroix, Isabelle
    Olivier, Pascale
    Durrieu, Genevieve
    Damase-Michel, Christine
    Lapeyre-Mestre, Maryse
    Bagheri, Haleh
    JOINT BONE SPINE, 2006, 73 (06) : 629 - 632
  • [48] Adverse drug reactions of oxetorone: Study in the French Pharmacovigilance Database
    Ginisty, S.
    Vitu, L.
    Geniaux, H.
    Bergeron, S.
    Pinel, S.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2022, 36 : 115 - 115
  • [49] Public Awareness of Adverse Drug Reactions and Pharmacovigilance System in Korea
    Lee, Jin
    Lee, Eunhee
    Jung, Jaewoo
    Kim, Minhye
    Kang, Hyeryun
    Cho, Sangheon
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 : 212 - 213
  • [50] Pharmacovigilance in pregnancy: adverse drug reactions associated with fetal disorders
    Wettach, Carmen
    Thomann, Janine
    Lambrigger-Steiner, Claudia
    Buclin, Thierry
    Desmeules, Jules
    von Mandach, Ursula
    JOURNAL OF PERINATAL MEDICINE, 2013, 41 (03) : 301 - 307
12345